Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Proteome Sciences, Meso Scale Discovery

Premium

Proteome Sciences had released its new β-amyloid mass spec workflow for quantification of Aβ species in cerebrospinal fluid.

The workflow is intended for research use and early stage clinical trial work and can detect and quantify 14 different Aβ species above 0.5 ng/ml with coefficients of variation of less than 20 percent, the company said.


Meso Scale Discovery has launched its V-PLEX biomarker tests, a line of validated immunoassays for clinical research.

Based on MSD's electrochemiluminescence Multi-Array technology, the assays focus on emerging biomarkers typically not available on traditional diagnostics platforms, the company said.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.